NFYB and glioblastoma: Moreover, we found that the proliferation, migration, and invasion ability of GBM were greatly reduced by knocking down NFYB; thus, we hypothesized that NFYB is a high-risk transcription factor for GBM and also has the possibility to be used as a potential therapeutic target.